Search clinical trials for: Talnetant

Total 4 results

GlaxoSmithKline

Completed

Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Irritable Colon

United States, Spain, South Africa, Sweden, Australia, Canada, Germany, United Kingdom, France, Netherlands
GlaxoSmithKline

Completed

Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients

Schizophrenia

United States
GlaxoSmithKline

Completed

Schizophrenia Study In Adults

Schizophrenia

United States
GlaxoSmithKline

Completed

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Schizophrenia

United States

3

Subscribe